NCT05853484

Brief Summary

Chronic liver disease eventually results in liver cirrhosis and is associated with an increasing deterioration in patients' physical fitness. As there is currently limited evidence regarding the effects of a home-based exercise program in patients with liver cirrhosis awaiting OLT, and physical frailty rates are particularly high in this patient population, this group has the investigators specific interest. The primary aim of this study is to assess the effect of a semi-supervised home-based bimodal lifestyle program, consisting of interval and endurance training and peripheral resistance training on aerobic capacity in patients with liver cirrhosis awaiting OLT

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 10, 2023

Completed
1.3 years until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

7 months

First QC Date

February 10, 2023

Last Update Submit

May 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Aerobic capacity

    The main study parameter/endpoint is the change in aerobic capacity after the first six weeks of the FIT4Cirrhotics@Home program, for which the following outcomes will be assessed: VO2 at the VAT (ml/kg/min). A cardiopulmonary exercise test will be performed by participants to determine their aerobic capacity pre-intervention and after six weeks of training.

    During baseline measurements patients will perform a cardiopulmonary exercise test to determine their baseline aerobic capacity. After 6 weeks of home-based training the cardiopulmonary exercise test will be repeated to reassess their aerobic capacity.

Secondary Outcomes (10)

  • Ultrasound measurements of muscle thickness

    through study completion, an average of 1 year

  • Anthropometry assessment

    through study completion, an average of 1 year

  • Functional mobility assessment

    through study completion, an average of 1 year

  • Quality of Life assessment

    through study completion, an average of 1 year

  • Perceived fatigue assessment

    through study completion, an average of 1 year

  • +5 more secondary outcomes

Study Arms (1)

Home based prehabilitation

EXPERIMENTAL

Participants will be subjected to two training periods of six weeks (or until transplantation) of a semi-supervised home-based bimodal lifestyle program. The bimodal lifestyle program consists of an exercise program combined with nutritional support. The exercise program comprises high intensity interval training and endurance training, combined with peripheral resistance training and breathing exercises

Other: Bimodal lifestyle program

Interventions

Participants will be subjected to two training periods of six weeks (or until transplantation) of a semi-supervised home-based bimodal lifestyle program. The bimodal lifestyle program consists of an exercise program combined with nutritional support. The exercise program comprises high intensity interval training and endurance training, combined with peripheral resistance training and breathing exercises

Home based prehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged at least 18 years;
  • Diagnosed with end-stage liver disease / liver cirrhosis (regardless of etiology);
  • On the waiting list for OLT;
  • VO2 at the VAT ≤13 ml/kg/min and/or VO2peak ≤18 ml/kg/min;
  • Speaks the Dutch language;
  • Understands the purpose of the study and has given written informed consent to participate in the study.

You may not qualify if:

  • Experienced a MACE (e.g., myocardial infarction) in the past six months;
  • Experienced a cerebrovascular incident in the past six months;
  • Medical history of an uncontrolled heart rhythm disorder;
  • Hepatic encephalopathy grade 3 or 4;
  • Acute liver failure;
  • Acute on chronic liver failure;
  • Hospitalization at start of the study;
  • Non-treated esophageal varices (i.e., variceal eradication endoscopy and/or adequately dosed NSBB);
  • MELD score ≥30;
  • Not capable of cycling on a cycle ergometer;
  • No available community physical therapist in the living area of the patient.
  • Patients refusing or unable to sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Groningen

Groningen, 9713 GZ, Netherlands

Location

Related Publications (1)

  • Wijma AG, Bongers BC, Annema C, Dekker R, Blokzijl H, van der Palen JA, De Meijer VE, Cuperus FJ, Klaase JM. 'Effects of a home-based bimodal lifestyle intervention in frail patients with end-stage liver disease awaiting orthotopic liver transplantation': study protocol of a non-randomised clinical trial. BMJ Open. 2024 Jan 29;14(1):e080430. doi: 10.1136/bmjopen-2023-080430.

MeSH Terms

Conditions

Liver CirrhosisSedentary Behavior

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2023

First Posted

May 10, 2023

Study Start

September 1, 2024

Primary Completion

April 1, 2025

Study Completion

August 1, 2025

Last Updated

May 16, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations